Access cutting-edge parkinson disease (pd) treatment through this clinical trial at a research site in Allston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Allston location
Preparing your pre-screening questions…
Access parkinson disease (pd) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related parkinson disease (pd) treatment provided free
Check if you qualify for this parkinson disease (pd) clinical trial in Allston, MA
No-Cost Study Care
Local to Allston
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Freezing-of-gait (FoG) in Parkinson Disease (PD) is one of the most vivid and disturbing gait phenomena in neurology. Often described by patients as a feeling of "feet getting glued to the floor," FoG is formally defined as a "brief, episodic absence or marked reduction of forward progression of the feet despite the intention to walk." This debilitating gait phenomena is very common in PD, occurring in up to 80% of individuals with severe PD. When FoG arrests walking, serious consequences can occur such as loss of balance, falls, injurious events, consequent fear of falling, and increased hospitalization. Wearable robots are capable of augmenting spatiotemporal gait mechanics and are emerging as viable solutions for locomotor assistance in various neurological populations. For the proposed study, our goal is to understand how low force mechanical assistance from soft robotic apparel can best mitigate gait decline preceding a freezing episode and subsequent onset of FoG by improving spatial (e.g. stride length) and temporal features (e.g. stride time variability) of walking. We hypothesize that the ongoing gait-preserving effects can essentially minimize the accumulation of motor errors that lead to FoG. Importantly, the autonomous assistance provided by the wearable robot circumvents the need for cognitive or attentional resources, thereby minimizing risks for overloading the cognitive systems -- a known trigger for FoG, thus enhancing the repeatability and robustness of FoG-preventing effects.
Sponsor: Harvard Medical School (HMS and HSDM)
Yes, this clinical trial (NCT06602544) has an active research site in Allston, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for parkinson disease (pd) treatment options in Allston, MA, this clinical trial (NCT06602544) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Allston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinson disease (pd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all parkinson disease (pd) clinical trials near you to find additional studies recruiting in your area.
See all parkinsons disease clinical trials recruiting in Allston — not just this study.
Browse Parkinsons Disease Trials in Allston →